Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD

Bone Marrow Transplantation

Volumn 47, Issue 7, 2012, Pages 981-984

  Sabti, S ^a   Halter, J P ^a   Braun Frankl B C ^a   Goldblum, D ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

keratoconjunctivitis sicca; ocular GvHD; punctal plug

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CORNEAL FLUORESCEIN STAINING; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JONES TEST; KERATOCONJUNCTIVITIS SICCA; MALE; MEDICAL DEVICE; NON INVASIVE PROCEDURE; OCULAR GRAFT VERSUS HOST REACTION; PRIORITY JOURNAL; PUNCTAL OCCLUSION; PUNCTAL PLUG; RATING SCALE; RETROSPECTIVE STUDY; SAFETY; SCHIRMER TEST; TEAR FILM BREAK UP TIME; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; FEMALE; GRAFT VS HOST DISEASE; HUMANS; KERATOCONJUNCTIVITIS SICCA; LACRIMAL APPARATUS; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84863716517     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.205     Document Type: Article

References (21)

1. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
2. Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 2003; 22: 19-27.
3. Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006; 25: 900-907.
4. Fawzi AA, Cunningham Jr ET. Central serous chorioretinopathy after bone marrow transplantation. Am J Ophthalmol 2001; 131: 804-805.
5. Kim SK. Update on ocular graft versus host disease. Curr Opin Ophthalmol 2006; 17: 344-348.
6. Kim RY, Anderiini P, Naderi AA, Rivera P, Ahmadi MA, Esmaeli B. Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation. Am J Ophthalmol 2002; 133: 843-845.
7. Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: v. ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant 2006; 12: 375-396.
8. Riemens A, te Boome L, Imhof S, Kuball J, Rothova A. Current insights into ocular graft-versus-host disease. Curr Opin Ophthalmol 2010; 21: 485-494.
9. Sakamoto A, Kitagawa K, Tatami A. Efficacy and retention rate of two types of silicone punctal plugs in patients with and without Sjogren syndrome. Cornea 2004; 23: 249-254.
10. Tai MC, Cosar CB, Cohen EJ, Rapuano CJ, Laibson PR. The clinical efficacy of silicone punctal plug therapy. Cornea 2002; 21: 135-139.
11. Murube J, Murube E. Treatment of dry eye by blocking the lacrimal canaliculi. Surv Ophthalmol 1996; 40: 463-480.
12. Levenson JE, Hofbaver J. Problems with punctal plugs. Arch Ophthalmol 1989; 107: 493-494.
13. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004; 137: 337-342.
14. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003; 31: 579-583.
15. Mansour K, Leonhardt CJ, Kalk WW, Bootsma H, Bruin KJ, Blanksma LJ. Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis sicca caused by Sjögren syndrome: a uniocular evaluation. Cornea 2007; 26: 147-150.
16. Gencoglu EA, Dursun D, Akova YA, Cengiz F, Yalcin H, Koyuncu A. Tear clearance measurements in patients with dry eye syndrome using qualitative lacrimal scintigraphy. Ann Nucl Med 2005; 19: 581-587.
17. Robinson MR, Lee SS, Rubin BI, Wayne AS, Pavletic SZ, Bishop MR et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graftversus-host disease. Bone marrow transplantation 2004; 33: 1031-1035.
18. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999; 106: 811-816.
19. Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M et al. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone marrow transplantation 2007; 41: 293-302.
20. Hemady R, Tauber J, Foster SC. Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol 1991; 35: 369-385.
21. Yen MT, Monroy D, Pflugfelder SC. Punctal occlusion decreases tear production, clearance and ocular surface Sensation. Invest Ophthalmol Vis Sci 1999; 40: S980.